Products

Idoven AI-powered Cardiovascular Care
Idoven
Cardiology AI
Idoven's AI-powered platform revolutionizes ECG interpretation, enabling early detection and precision medicine by detecting 23 unique cardiac patterns.

See all 1 product →

About Idoven

Idoven is a pioneering health technology company that leverages artificial intelligence to transform cardiovascular disease detection and precision medicine. Their core offering is the AI-powered platform, Willem™, which significantly enhances the speed, consistency, and accuracy of electrocardiogram (ECG) interpretation and prediction. The platform is designed to integrate seamlessly into clinical workflows, assisting physicians in triaging cardiac events and identifying cardiovascular diseases earlier. Idoven’s AI algorithms can analyze 50,000 heartbeats in 60 seconds and identify 86 electrical heart disturbances, covering 90% of common cardiac problems.

For physicians, Idoven’s technology addresses the challenges of an overburdened healthcare system and the increasing volume of ECG data from wearable devices. The platform reduces the manual and repetitive workload of ECG analysis, which can take cardiologists hours using traditional methods, allowing them to focus more on direct patient care. Idoven’s device-neutral software can analyze data from various sources, including 1-lead wearables, patches, and 12-lead hospital ECGs, providing a comprehensive and standardized view of a patient’s cardiac history. Beyond diagnosis, Idoven also develops predictive ECG-based AI models for prognostic tools, such as identifying patients at risk of developing persistent atrial fibrillation. They also collaborate with pharmaceutical companies to develop disease biomarkers for patient identification, risk stratification, prognosis, and cardiac drug safety monitoring.

Focus Areas

cardiovascular disease detection arrhythmia detection ECG interpretation precision medicine preventative screening cardiac drug safety monitoring AI in cardiology

Business Intelligence

Technologycloud-based AI software (Willem™), proprietary deep learning system, device-neutral (compatible with 1-pin wearables to 12-pin hospital ECGs)

What Physicians Need to Know

Cardiovascular Disease Detection & Arrhythmia Detection
Idoven's AI-powered platform, Willem, analyzes ECGs to detect and triage over 80 of the most frequent cardiac patterns, covering 90% of the global population, with over 90% global accuracy. It can identify 86 electrical heart disturbances and 23 unique cardiac patterns. This includes conditions like atrial fibrillation, cardiotoxicity, and QT prolongation.
ECG Interpretation
Idoven significantly improves the speed, consistency, and accuracy of ECG interpretation, providing cardiologist-level accuracy. Their AI can make the same accurate diagnosis in about eight minutes that traditionally takes a cardiologist eight hours. The platform is device-neutral, integrating with any existing ECG hardware (e.g., ambulatory, Holter, resting, stress tests, mobile cardiac telemetry, insertable loop recorders, wearables/smartwatches) and can read various ECG signal formats (JSON, DICOM, EDF, CSV).
Precision Medicine & Preventative Screening
Idoven develops disease biomarkers from ECGs for patient identification, risk stratification, and prognosis. Their AI models can predict the evolution of atrial fibrillation within six months, even for patients with no prior history. They offer comprehensive preventative screening programs with continuous remote ECG monitoring and medical-grade reports.
Cardiac Drug Safety Monitoring
The platform aids in monitoring cardiac drug safety, including rapid detection and monitoring for drug cardiotoxicity and QT prolongation, both in-office and remotely.
AI in Cardiology & Technology Stack
Idoven's core is a cloud-based, AI-powered software called Willem, which leverages proprietary deep learning algorithms. Their AI models are trained on one of the world's largest and most diverse ECG databases, with over 1.8 million hours of ECG data from more than 49,000 patients. The platform is designed for seamless integration into existing clinical workflows and hospital systems.
Key Differentiators
Idoven offers the most comprehensive solution for triaging and detecting cardiac arrhythmias with cardiologist-level accuracy (over 90% global accuracy). They provide prediction of atrial fibrillation up to six months in advance with only physiological data. Their device-neutral approach allows integration with any ECG hardware and various data formats. The platform is certified as a Medical Device Class IIa under EU MDR and adheres to high international standards for patient data security (ISO 27001, 27017, 27018, 27701).
Physician Tip

Idoven's platform, Willem, acts as a 'Digital Cardiologist in the Cloud,' augmenting your ability to identify, triage, and diagnose patients at scale. It provides rapid, accurate ECG analysis, reducing interpretation time from hours to minutes, and can help manage the increasing demand for cardiovascular care. The system is designed to integrate into existing workflows, supporting decision-making and disease management. It's particularly valuable for early detection, risk stratification, and monitoring drug safety, enabling more precise and timely interventions. Remember that Willem's interpretation results are advisory and should be used in conjunction with your clinical knowledge, patient background, and other diagnostic information.

Idoven's platform is highly interoperable, offering API integration with any existing ECG hardware, hospital systems, and Electronic Health Records (EHRs). It supports various ECG signal formats including JSON, DICOM, EDF, and CSV, ensuring seamless data exchange. This device-neutral approach allows for flexibility in integrating with diverse clinical environments and monitoring devices, from wearables to hospital-grade ECGs.

Products by Idoven

1 product in the directory

Idoven AI-powered Cardiovascular Care
Idoven
Cardiology AI
Idoven's AI-powered platform revolutionizes ECG interpretation, enabling early detection and precision medicine by detecting 23 unique cardiac patterns.

What the Web Says

Idoven is a Spanish health tech startup that utilizes AI to redefine the diagnosis and prevention of cardiovascular diseases. Their AI-powered platform, Willemu2122, aims to improve the speed, consistency, and accuracy of ECG interpretation and prediction, ultimately assisting cardiologists and enhancing patient care. The company has partnered with major medical device and pharmaceutical companies, including Abbott and GE HealthCare, to integrate its technology into clinical workflows and research. Reviews highlight the impressive accuracy of their AI technology and the professionalism of their team.

Overall: Positive

Strengths

  • Outstanding AI accuracy and innovative solutions.
  • Organizes workflows and improves operational efficiency.
  • Team is well-informed, professional, and supportive.
  • Significantly reduces false positives in arrhythmia detection (up to 98%).
  • Achieves high accuracy in detecting arrhythmias (up to 95.6%).
  • Reduces cardiologist workload and allows focus on urgent cases.

Limitations

  • Limited number of publicly available reviews.
  • Some platforms like Glassdoor and Capterra have no specific reviews for Idoven.
  • No drawbacks explicitly mentioned in the available product reviews.

Based on reviews from: Software Finder, SoftwareSuggest, GE HealthCare, CNN Business, PR Newswire, Insight Partners

Last updated: 2026-10-03

Videos

News, demos, and interviews about Idoven.

Loading videos...

Videos load interactively. If none appear, search YouTube for Idoven →

View all on YouTube

Press & Coverage

PR Newswire
Idoven Raises $19.8 Million in Funding to Redefine Detection and Precision Medicine of Cardiovascular Diseases with AI
Idoven, a health tech company, secured $19.8 million in funding, including a $12.9 million Series A round and $6.9 million in EIC Accelerator grants, to advance its AI platform for cardiovascular disease detection.
2022-06
Idoven
Idoven acquires NVIDIA DGX systems to advance its mission of revolutionizing cardiovascular disease diagnosis with AI
Idoven has invested in NVIDIA DGX H100 systems to accelerate its AI algorithm training and validation for cardiovascular disease diagnosis, with Telefónica providing data center infrastructure.
2024-07
GE HealthCare
Health tech start-up uses AI to redefine cardiology care
Idoven is leveraging AI to assist cardiologists in interpreting large volumes of ECG data quickly and accurately, aiming to improve early diagnosis and precision medicine for cardiovascular diseases.
2023-05
EIT Health
EIT Health-supported Idoven raises u20ac18.5M
Idoven, supported by EIT Health, raised u20ac18.5 million to further develop its AI platform for early detection and precision treatment of cardiovascular disease.
2022-07
Idoven
EIT Health funds the ASSIST project with u20ac1.5M from the startup Idoven for early diagnosis of myocardial infarction
Idoven's ASSIST project received u20ac1.5 million in funding from EIT Health to develop an AI-based solution for early and accurate diagnosis of acute myocardial infarction.
2023-07
Idoven
AstraZeneca and Idoven launch the CONCERTO project to improve early diagnosis of patients with amyloidosis
AstraZeneca and Idoven launched the CONCERTO project to develop and validate an AI model within Idoven's Willemu2122 platform for early detection of amyloidosis through ECG analysis.
2025-05
Idoven
AstraZeneca and Idoven are using Artificial Intelligence to diagnose heart failure through a pioneering project in Europe
AstraZeneca and Idoven are collaborating on a European project utilizing AI and Fitbit wearable devices to detect and monitor heart failure patients, aiming for personalized healthcare and early diagnosis.
2022-11
Idoven
Willem, Idoven's AI Platform, achieves 96.4% accuracy in atrial fibrillation detection from 1-lead ECGs
Idoven's AI-powered ECG analysis platform, Willem, demonstrated 96.4% accuracy in detecting atrial fibrillation from single-lead ECGs in a large-scale validation study published in the Heart Rhythm Journal.
2025-02

Frequently Asked Questions

Idoven's AI platform, Willem, is capable of detecting 22 unique cardiac patterns and 4 intervals (P Interval, PR Interval, QT Interval, and QRS duration) with cardiologist-level accuracy. It can also identify 86 electrical heart disturbances, covering 90% of the most common cardiac problems. The platform has shown significant improvements in arrhythmia detection, expanding from 4 to 25 cardiac patterns in some applications.
Idoven's solution is designed for seamless integration with existing clinical workflows, including Home Monitoring and Electronic Health Record (EHR) systems, via API or non-API tools. Their Willem ECG analysis platform is certified as a Class IIa Medical Device under the EU Medical Device Regulation (MDR) 2017/745, ensuring compliance with rigorous safety and performance requirements. Idoven also adheres to GDPR and has ISO 27001, 27017, 27018, 27701, 13485, 37001, and 42001 certifications for data security and privacy.
Idoven's AI models are trained on one of the largest and most diverse ECG databases, comprising 1.8 million ECG hours from over 28,500 subjects. Studies have demonstrated high accuracy, with one showing 95.4% accuracy for arrhythmia classification and a 98% reduction in false positives when integrated with Abbott's ICM devices. Their AI can also predict the evolution of atrial fibrillation within six months with just physiological data.
Idoven develops disease risk scores using ECG-based biomarkers to identify high-risk, undiagnosed, or undertreated patients, aiding in the prediction of potential cardiovascular diseases. For preventative screening, they offer continuous remote ECG monitoring with non-invasive devices, providing medical-grade reports analyzed by their algorithms and cardiologists.
Yes, Idoven's solution helps clinicians monitor cardiac drug safety by developing ECG-based disease biomarkers and streamlining cardiovascular safety monitoring during clinical trials and post-market approval. They have partnered with pharmaceutical companies to develop AI algorithms for rapid detection and monitoring of cardiotoxicity, such as QT prolongation, in cancer patients.
Idoven partners with leading medical device and pharmaceutical companies, including AstraZeneca, Abbott, GE Healthcare, and Medtronic, to drive AI-driven innovations in cardiovascular care. They have also collaborated with Google for Startups and received funding from various investors. The company has demonstrated growth, expanding its team and global reach to over 30 countries.
While specific pricing models are not publicly detailed, Idoven offers its AI-powered cardiology-as-a-service platform to augment clinicians' abilities to identify, triage, and diagnose patients at scale. Their solutions are designed to reduce the manual workload of ECG interpretation, improve efficiency, and provide faster, more accurate diagnoses. They aim to provide clinical support with a team of expert cardiologists to supervise ECG interpretation.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]

NeurixaHealthAI™ is a healthcare AI company dedicated to eliminating administrative waste in the healthcare system, which they estimate to be $1.1 trillion annually. They offer a production-ready healthcare intelligence platform designed to simplify operations, improve outcomes, and accelerate the journey from patient care to financial performance. The platform is not a collection of point solutions […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.